Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival

Transplant Proc. 1999 Feb-Mar;31(1-2):95. doi: 10.1016/s0041-1345(98)01455-9.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • CD40 Antigens / immunology
  • CD40 Ligand
  • Graft Rejection / immunology
  • Graft Rejection / pathology
  • Graft Survival / immunology*
  • Heart Transplantation / immunology*
  • Heart Transplantation / pathology
  • Immunosuppression Therapy / methods
  • Ligands
  • Lymphocytes / immunology
  • Lymphocytes / pathology
  • Macaca fascicularis
  • Membrane Glycoproteins / antagonists & inhibitors*
  • Membrane Glycoproteins / immunology
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • CD40 Antigens
  • Ligands
  • Membrane Glycoproteins
  • CD40 Ligand